A Study to Evaluate Abemaciclib in Advanced Biliary Tract Carcinoma

NCT04003896 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped The manufacturer and funder Eli Lilly requested to terminate the study

Conditions

Biliary Tract Carcinoma

Interventions

DRUG: Abemaciclib

Sponsor

Milton S. Hershey Medical Center

Collaborators

[object Object]